Patents by Inventor Fusako Maehira

Fusako Maehira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7919620
    Abstract: The antihypertensive agent of the present invention contains a soluble silicon compound. The soluble silicon compound is preferably metasilicic acid or a salt thereof. In one embodiment, the antihypertensive agent of the present invention contains deep sea water containing the soluble silicon compound, or a dried product of such deep sea water. It is preferred that in such embodiment, the antihypertensive agent further contains metasilicic acid or a salt thereof. The amount of silicon present in the deep sea water in the form of silicic acid (SiO2—Si) is 25 ?M or more. The deep sea water is typically collected at a depth of 300 m or deeper, and preferably at a depth of 600 m or deeper.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: April 5, 2011
    Assignee: Coral Biotech Kabushiki Kaisha
    Inventor: Fusako Maehira
  • Publication number: 20100028457
    Abstract: An object is to find a natural material having an activity of preventing the elevation of blood glucose level and to provide a means which is able to prevent or treat the diabetes and there is provided an agent for prevention or treatment of the elevated blood glucose level where a compound containing soluble silica and/or strontium is an active ingredient.
    Type: Application
    Filed: September 6, 2007
    Publication date: February 4, 2010
    Applicants: UNIVERSITY OF THE RYUKYUS, CORAL BIOTECH KK
    Inventor: Fusako Maehira
  • Publication number: 20080076734
    Abstract: The antihypertensive agent of the present invention contains a soluble silicon compound. The soluble silicon compound is preferably metasilicic acid or a salt thereof. In one embodiment, the antihypertensive agent of the present invention contains deep sea water containing the soluble silicon compound, or a dried product of such deep sea water. It is preferred that in such embodiment, the antihypertensive agent further contains metasilicic acid or a salt thereof. The amount of silicon present in the deep sea water in the form of silicic acid (SiO2—Si) is 25 ?M or more. The deep sea water is typically collected at a depth of 300 m or deeper, and preferably at a depth of 600 m or deeper.
    Type: Application
    Filed: June 1, 2005
    Publication date: March 27, 2008
    Applicant: CORAL BIOTECH KABUSHIKI KAISHA
    Inventor: Fusako Maehira